Literature DB >> 16951180

N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.

Beryl A Hatton1, Paul S Knoepfler, Anna Marie Kenney, David H Rowitch, Ignacio Moreno de Alborán, James M Olson, Robert N Eisenman.   

Abstract

We examined the genetic requirements for the Myc family of oncogenes in normal Sonic hedgehog (Shh)-mediated cerebellar granule neuronal precursor (GNP) expansion and in Shh pathway-induced medulloblastoma formation. In GNP-enriched cultures derived from N-myc(Fl/Fl) and c-myc(Fl/Fl) mice, disruption of N-myc, but not c-myc, inhibited the proliferative response to Shh. Conditional deletion of c-myc revealed that, although it is necessary for the general regulation of brain growth, it is less important for cerebellar development and GNP expansion than N-myc. In vivo analysis of compound mutants carrying the conditional N-myc null and the activated Smoothened (ND2:SmoA1) alleles showed, that although granule cells expressing the ND2:SmoA1 transgene are present in the N-myc null cerebellum, no hyperproliferation or tumor formation was detected. Taken together, these findings provide in vivo evidence that N-myc acts downstream of Shh/Smo signaling during GNP proliferation and that N-myc is required for medulloblastoma genesis even in the presence of constitutively active signaling from the Shh pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951180     DOI: 10.1158/0008-5472.CAN-06-1621

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  80 in total

1.  Role of Myc Proto-Oncogene as a Transcriptional Hub to Regulate the Expression of Regeneration-Associated Genes following Preconditioning Peripheral Nerve Injury.

Authors:  Hae Young Shin; Min Jung Kwon; Eun Mi Lee; Kyung Kim; Young Joo Oh; Hyung Soon Kim; Dong Hoon Hwang; Byung Gon Kim
Journal:  J Neurosci       Date:  2020-12-01       Impact factor: 6.167

2.  BMPs oppose Math1 in cerebellar development and in medulloblastoma.

Authors:  Matthew R Grimmer; William A Weiss
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

Review 3.  Dynamic signaling for neural stem cell fate determination.

Authors:  Shu Wen; Hong Li; Jia Liu
Journal:  Cell Adh Migr       Date:  2009-01-10       Impact factor: 3.405

4.  Pleiotropic role for MYCN in medulloblastoma.

Authors:  Fredrik J Swartling; Matthew R Grimmer; Christopher S Hackett; Paul A Northcott; Qi-Wen Fan; David D Goldenberg; Jasmine Lau; Selma Masic; Kim Nguyen; Slava Yakovenko; Xiao-Ning Zhe; Heather C Flynn Gilmer; Rodney Collins; Mai Nagaoka; Joanna J Phillips; Robert B Jenkins; Tarik Tihan; Scott R Vandenberg; C David James; Kohichi Tanaka; Michael D Taylor; William A Weiss; Louis Chesler
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

5.  Metastatic Basal Cell Carcinoma.

Authors:  Alvaro C Laga; Inga Marie Schaefer; Lynette M Sholl; Christopher A French; John Hanna
Journal:  Am J Clin Pathol       Date:  2019-11-04       Impact factor: 2.493

6.  N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b.

Authors:  Rebecca Cotterman; Paul S Knoepfler
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

7.  One Decade Later: What has Gene Expression Profiling Told us About Neuronal Cell Types, Brain Function and Disease?

Authors:  Elva Díaz
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

8.  c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.

Authors:  Alice Wey; Paul S Knoepfler
Journal:  Oncotarget       Date:  2010-06

9.  Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathway.

Authors:  Motoshi Nagao; Kenneth Campbell; Kevin Burns; Chia-Yi Kuan; Andreas Trumpp; Masato Nakafuku
Journal:  J Cell Biol       Date:  2008-12-29       Impact factor: 10.539

10.  Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.

Authors:  Frank Westermann; Daniel Muth; Axel Benner; Tobias Bauer; Kai-Oliver Henrich; André Oberthuer; Benedikt Brors; Tim Beissbarth; Jo Vandesompele; Filip Pattyn; Barbara Hero; Rainer König; Matthias Fischer; Manfred Schwab
Journal:  Genome Biol       Date:  2008-10-13       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.